Q515 - Notice of Intent to Sole-Source Requirement: Artera AI Prostate Exam Testing - Cleveland VAMC
Updated
Special Notice from the Department of Veterans Affairs, for work in Ohio. Due Nov 10, 2026, 3:00 PM (UTC-5), 7 days left.
| Solicitation number | 36C25027Q0088 |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | 250-Network Contract Office 10 (36C250) |
| Notice type | Special Notice |
| Set-aside | None |
| Trade (NAICS) | Testing Laboratories and Services (541380) |
| Product or service code | Q515 |
| Place of performance | Ohio |
| Posted | Nov 2, 2026 |
| Response deadline | Nov 10, 2026, 3:00 PM (UTC-5) (7 days left) |
| Add the deadline to | Google Calendar · Apple / Outlook (.ics) |
Federal prevailing wage rates for this place: Ohio Davis-Bacon and SCA wage determinations.
Description
Notice of Intent to Sole-Source Requirement The Department of Veterans Affairs, Network Contracting Office (NCO) 10, intends to negotiate a sole source contract under Simplified Acquisition Procedures and the authority of FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The associated NAICS code for this is 541380, Size Standard is $19 Million.
Product Service Code (PSC) is Q515. The sole-source contract will be awarded to: ARTERA, INC UEI: S8PHW2AWT2R7 Description of requirements: The VA Northeast Ohio Healthcare System (VANEOHS) requires access to specialized multi-modal artificial intelligence (MMAI) prostate risk stratification testing of prostate biopsies or surgical specimens to assess the likelihood and severity of prostate recurrence or progression.
Multi-modal artificial intelligence (MMAI) is a precision medicine platform designed to optimize cancer treatment, primarily for prostate and breast cancer patients. This testing consists of the following to generate patient specific prostate cancer risk stratification: Data Integration: Artera AI analyzes H&E-stained pathology slides alongside patient clinical information, such as age, tumor stage, and lab results; Predictive Modeling: The AI algorithm predicts which patients are likely to benefit from specific therapies, such as short-term androgen deprivation therapy (ST-ADT) in prostate cancer; Outcome Estimation: It estimates long-term outcomes, including disease progression and metastasis risk, helping clinicians tailor treatment plans Artera AI Prostate is the first MMAI test recommended in the NCCN Clinical Practice Guidelines for prostate cancer.
It identifies patients who may benefit most from hormone therapy and supports early-stage treatment decisions. Benefits of this testing are early intervention providing actionable insights to guide therapy selection and improve patient outcomes for our prostate cancer patients. It is the Government's belief that only the proposed candidate possesses the required capabilities to successfully meet this requirement.
It is the Government's intention to solicit and negotiate with only this source. This notice of intent is not a request for competitive proposals. IAW FAR 5.207 all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.
This is not a solicitation or request for offers. No solicitation package is available. Any response to this notice must show clear and convincing evidence that demonstrates the ability to comply with the requirement and that competition would be advantageous to the Government.
The Government will not pay for information submitted. A determination not to compete based on responses to this notice is solely within the discretion of the Government. All responses to this intent to sole source must be emailed to Thomas Bellamy: [email protected] and Samantha Jarrett: [email protected] by 3:00 p.m. EST November 10th, 2026.
Contracting contact
- Thomas Bellamy · [email protected]
- Samantha Jarrett · [email protected]
As published on the official notice. Ask questions in writing and before any questions deadline the notice sets.
Is your business small enough?
For NAICS 541380, a business counts as small if it has no more than $19.0 million in average annual receipts (SBA size standard). This notice is set aside, so only businesses under that size, or in the named program, can bid. SBA table, current as of Oct 15, 2026.
Companies that win this kind of work
Federal contractors paid for testing laboratories and services work, who also hold VA contracts (last 12 months): possible competitors, or partners to team with.
- Emory University $19.8 million in this trade
- Infinity Biologix LLC $15.1 million in this trade
- Tempus AI, Inc $13.6 million in this trade
- University Of California, Davis $8.4 million in this trade
- Azenta US Inc $7.3 million in this trade
About the buyer
The Department of Veterans Affairs awarded $84.6 billion in contracts in the last 12 months; its biggest suppliers were Optum Public Sector Solutions, Inc., Mckesson Corporation and Triwest Healthcare Alliance Corp. See what VA is buying now.
Testing Laboratories and Services contracts right now
There are 39 open government contract opportunities in this trade (NAICS 541380), 20 posted in the last 7 days; 56% are set aside for small businesses. The agencies buying the most are Department of Veterans Affairs, Department of the Army and Departmental Offices. Most of the work with a stated place is in Illinois, Maryland and Indiana. A notice in this trade gives a median of 15 days from posting to deadline; this one gives 8 days.
All open testing laboratories and services contracts
Coming up in this trade
Planned contracts from the agencies' procurement forecasts, often months before a solicitation. Plans can change.
Recent awards in this trade
- Vitisystems, Inc. $6,600 · Departmental Offices · Oct 26, 2026
- Idaho Department Of Fish Game $5,835 · Departmental Offices · Oct 20, 2026
- Force Inspection, LLC $2,315 · Department of the Army · Oct 23, 2025
From the award notices agencies publish.